EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Bristol Myers Squibb (NYSE:BMY) Trading 1.9% Higher After Analyst Upgrade
Rep. Gilbert Ray Cisneros, Jr. Buys Bristol Myers Squibb Company (NYSE:BMY) Shares
Bristol-Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos in Adolescent Patients
Healthy Returns: Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
Manning & Napier Advisors LLC Lowers Stake in Bristol Myers Squibb Company $BMY
Cullinan Associates Inc. Trims Stock Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Manning & Napier Advisors LLC - Daily Political
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study
Is Bristol Myers Squibb (BMY) Pricing Reflect Long Term Cash Flow Prospects At US$55.92?
Leerink Partners Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price
Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth
10 Cheap S&P 500 Stocks to Invest in Now
Oramed and Lifeward Announce Strategic Transaction PR Newswi
Bristol Myers Squibb Company $BMY Shares Sold by GRIMES & Co WEALTH MANAGEMENT LLC
Cheaper Cancer Drugs vs Patents: Will Delhi HC's Zydus Ruling Expand Access To Treatment? | Explainers News - News18
Bristol Myers Squibb Company $BMY Position Raised by Sumitomo Mitsui Trust Group Inc. - Daily Political
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Scotiabank Raises Bristol-Myers (BMY) PT to $60 Citing Catalyst-Rich 2026 Growth
SAN FRANCISCO-Bristol Myers…
Critical Review: Bristol Myers Squibb (NYSE:BMY) & VivoSim Labs (NASDAQ:VIVS) - Markets Daily
First Horizon Corp Acquires New Holdings in Bristol Myers Squibb Company $BMY
Head to Head Comparison: VivoSim Labs (NASDAQ:VIVS) & Bristol Myers Squibb (NYSE:BMY) - Stock Observer
Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab - The Economic Times
Tema Etfs LLC Purchases 25,997 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat
Here are the 3 big things we're watching in the stock market in the week ahead
Bristol Myers Squibb Company $BMY Shares Bought by New York State Teachers Retirement System - Daily Political
Nepsis Inc. Decreases Stake in Bristol Myers Squibb Company $BMY
Nisa Investment Advisors LLC Purchases 83,401 Shares of Bristol Myers Squibb Company $BMY
MADDEN SECURITIES Corp Sells 23,426 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Oregon Public Employees Retirement Fund Buys 56,749 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Did UBS's Pipeline-Driven Upgrade Just Shift Bristol-Myers Squibb's (BMY) Investment Narrative?
Next Level Private LLC Has $2.54 Million Position in Bristol Myers Squibb Company $BMY
The Motley Fool: What's 'the Dow'? - UPSTATE BUSINESS JOURNAL
SG Americas Securities LLC Has $75.53 Million Stake in Bristol Myers Squibb Company $BMY
SG Americas Securities LLC Buys 1,177,732 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves?
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Assessing Bristol Myers Squibb (BMY) Valuation As Shares Gain And Profitability Narrative Evolves
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - SPONSOR CONTENT FROM EY-PARTHENON
UBS Group Upgrades Bristol Myers Squibb (NYSE:BMY) to Buy
Bristol Myers Squibb (NYSE:BMY) Rating Increased to Buy at UBS Group - Markets Daily
Integras Partners LLC Buys 22,141 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC
Oncology Biosimilars: Biocon to Launch Keytruda Biosimilars at JPM 2026 Conference, ETPharma
Assessing Bristol Myers Squibb (BMY) Valuation After New Eliquis Pact Trial Update And Opdivo Approval
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Gladstone Institutional Advisory LLC Has $4.50 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Position Decreased by D.A. Davidson & CO.
Robeco Institutional Asset Management B.V. Buys 409,231 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Is Bristol Myers Squibb (BMY) Pricing Reflect Pipeline Progress And DCF Valuation Gap
Railway Pension Investments Ltd Purchases 40,300 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by CWA Asset Management Group LLC
The Motley Fool: Dividends and a chance for growth
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference
Allspring Global Investments Holdings LLC Acquires 434,745 Shares of Bristol Myers Squibb Company $BMY
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Bristol Myers Squibb Sees Unusually Large Options Volume (NYSE:BMY) - Markets Daily
Drugmakers hike US prices on 350 medicines despite pressure from Trump
Bristol Myers Squibb Sees Unusually High Options Volume (NYSE:BMY) - Stock Observer
VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stock Holdings in Bristol Myers Squibb Company $BMY
3Chopt Investment Partners LLC Sells 36,326 Shares of Bristol Myers Squibb Company $BMY
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires 679,000 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating
Bristol Myers Squibb Company $BMY Shares Purchased by Fort Washington Investment Advisors Inc. OH
Bristol Myers Squibb Company $BMY Shares Sold by Range Financial Group LLC
Ethic Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY
What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)?
Biotech Stocks Facing FDA Decision In January 2026
Bristol Myers Squibb Company $BMY Stock Holdings Reduced by Valley National Advisers Inc.
Spotlight | - The Times of India
An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments
Bristol Myers Squibb Company $BMY Shares Bought by Cwm LLC
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
Donald L. Hagan LLC Purchases Shares of 20,550 Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Pacer Advisors Inc. - Stock Observer
Trust Co. of Toledo NA OH Increases Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
Medical Stocks Worth Watching - December 25th - Daily Political
Bristol Myers Squibb (BMY): Reassessing Valuation After Breyanzi's Landmark FDA Approval in Marginal Zone Lymphoma
Vontobel Holding Ltd. Sells 46,675 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
Vontobel Holding Ltd. Lowers Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound?
Bristol Myers Squibb Accelerates Drug Launches in India with AI Innovations, ETPharma
Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact
Bristol Myers lines up many launches for India with 'AI' speed - The Economic Times
Four quiet Q4 winners and what the stocks must do to keep rolling in 2026
U.S. Capital Wealth Advisors LLC Sells 47,717 Shares of Bristol Myers Squibb Company $BMY
